In detail, the IDO1-negative tumors had significantly higher mitotic counts, higher histologic grades and scores, and reduced ER-α or PR scores than the IDO1-positive tumors with 11–100% positive tumor cells. The gene discussed is PGR; the disease is neoplasm.